spot_img

Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies

MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004,...

Creyon Bio Appoints Venture Capitalists Serge Messerlian and Shaquille Vayda to Board of Directors

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a clinical-stage leader in AI/machine...

Top Stories

admin

Avacta to present updated clinical data on AVA6000 at the European...

        8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments...
admin

SDAIA to Unveil Key AI Strategies and International Collaborations at Global...

RIYADH, Saudi Arabia, Sept. 9, 2024 /PRNewswire/ -- The Saudi Authority for Data and Artificial Intelligence (SDAIA) will hold a press conference on Sunday, September 8, at the King Abdulaziz International Conference Center. The press conference will highlight key aspects of the upcoming third edition of the Global AI...

Most Popular

People

Vegan Cosmetics and Personal Care Ingredients Industry research 2024-2034: Rising Demand...

admin
People

Global Coffee Beauty Products Market Size To Worth USD 969.3 Million...

admin
People

The 19th China International Mountain Outdoor Sports Open opens in southwest...

admin
People

A Journey to Discover the Beauty of Arxan in Hinggan League,...

admin
People

KV Construction Expands Siding Services to Everett, WA

admin
admin

Westwood Hart Announces Launch of New Retail E-commerce Platform

Malibu, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Westwood Hart, a bespoke tailoring company with over five decades of experience, has announced the launch of its new retail e-commerce platform. This development marks a significant expansion in the company’s operations, enabling it to offer its...
admin

Oncopeptides expands on WODA partnership with addition of Africa and Eurasia...

ZURICH and ZUG, Switzerland and STOCKHOLM, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Veld Pharmaceuticals GmbH (“Veld”) and Slavpharma GmbH (“Slavpharma”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in Africa and...

Category

AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate...

admin

Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to...

admin